Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion Lymphoma.

Mirza AS, Dholaria BR, Hussaini M, Mushtaq S, Horna P, Ravindran A, Kumar A, Ayala E, Kharfan-Dabaja MA, Bello C, Chavez JC, Sokol L.

Clin Lymphoma Myeloma Leuk. 2019 Mar 29. pii: S2152-2650(18)31746-4. doi: 10.1016/j.clml.2019.03.021. [Epub ahead of print]

PMID:
31253594
2.

Single Antibody Detection of T-Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance.

Shi M, Jevremovic D, Otteson GE, Timm MM, Olteanu H, Horna P.

Cytometry B Clin Cytom. 2019 Apr 11. doi: 10.1002/cyto.b.21782. [Epub ahead of print]

PMID:
30972977
3.

Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation.

Patnaik MM, Pophali PA, Lasho TL, Finke CM, Horna P, Ketterling RP, Gangat N, Mangaonkar AA, Pardanani A, Tefferi A.

Haematologica. 2019 Jun;104(6):e236-e239. doi: 10.3324/haematol.2018.208082. Epub 2019 Jan 3. No abstract available.

4.

Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.

Horna P, Moscinski LC, Sokol L, Shao H.

Cytometry B Clin Cytom. 2019 May;96(3):234-241. doi: 10.1002/cyto.b.21738. Epub 2018 Oct 16.

PMID:
30328260
5.

Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty-nine patients.

Pophali P, Horna P, Lasho TL, Finke CM, Ketterling RP, Gangat N, Nagorney D, Tefferi A, Patnaik MM.

Am J Hematol. 2018 Nov;93(11):1347-1357. doi: 10.1002/ajh.25246. Epub 2018 Oct 5.

PMID:
30105755
6.

Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients.

Higgins A, Mangaonkar AA, Hefazi M, Viswanatha D, Horna P, Foran J, Gangat N.

Leuk Res. 2018 Sep;72:1-4. doi: 10.1016/j.leukres.2018.07.018. Epub 2018 Jul 21. No abstract available.

PMID:
30055376
7.

Transformation of T-Cell Acute Lymphoblastic Lymphoma to Peripheral T-Cell Lymphoma: A Report of Two Cases.

Markow M, Mirza AS, Perez L, Shao H, Horna P, Anasetti C, Sokol L, Hussaini MO.

Case Rep Hematol. 2018 Feb 28;2018:9191582. doi: 10.1155/2018/9191582. eCollection 2018.

8.

Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.

Perez L, Fernandez H, Horna P, Riches M, Locke F, Field T, Powers J, Sahakian E, Villagra A, Mishra A, Betts B, Kharfan-Dabaja M, Beato F, Ochoa-Bayona L, Pidala J, Anasetti C.

Bone Marrow Transplant. 2018 Nov;53(11):1434-1444. doi: 10.1038/s41409-018-0163-z. Epub 2018 Apr 18.

PMID:
29670210
9.

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.

Betts BC, Bastian D, Iamsawat S, Nguyen H, Heinrichs JL, Wu Y, Daenthanasanmak A, Veerapathran A, O'Mahony A, Walton K, Reff J, Horna P, Sagatys EM, Lee MC, Singer J, Chang YJ, Liu C, Pidala J, Anasetti C, Yu XZ.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1582-1587. doi: 10.1073/pnas.1712452115. Epub 2018 Jan 30.

10.

Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.

Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC 3rd, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, C Tardio J, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RN.

Am J Surg Pathol. 2018 Mar;42(3):293-305. doi: 10.1097/PAS.0000000000000985.

PMID:
29194092
11.

Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature.

Horna P, Shao H, Idrees A, Glass LF, Torres-Cabala CA.

J Cutan Pathol. 2017 Nov;44(11):958-963. doi: 10.1111/cup.13017. Epub 2017 Sep 6. Review.

PMID:
28880462
12.

Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology.

Sahakian E, Chen J, Powers JJ, Chen X, Maharaj K, Deng SL, Achille AN, Lienlaf M, Wang HW, Cheng F, Sodré AL, Distler A, Xing L, Perez-Villarroel P, Wei S, Villagra A, Seto E, Sotomayor EM, Horna P, Pinilla-Ibarz J.

J Leukoc Biol. 2017 Aug;102(2):475-486. doi: 10.1189/jlb.1A0415-176RRR. Epub 2017 May 26.

13.

Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function.

Betts BC, Veerapathran A, Pidala J, Yang H, Horna P, Walton K, Cubitt CL, Gunawan S, Lawrence HR, Lawrence NJ, Sebti SM, Anasetti C.

Sci Transl Med. 2017 Jan 11;9(372). pii: eaai8269. doi: 10.1126/scitranslmed.aai8269.

14.

EBV-positive Richter's syndrome with laboratory features of Burkitt's lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia.

Hussaini MO, Rehman A, Chavez JC, Pinilla-Ibarz J, Horna P.

Leuk Lymphoma. 2017 Jul;58(7):1753-1756. doi: 10.1080/10428194.2016.1256482. Epub 2016 Nov 16. No abstract available.

PMID:
27852142
15.

Lymphomatoid Granulomatosis: A Single Institution Experience and Review of the Literature.

Chavez JC, Sandoval-Sus J, Horna P, Dalia S, Bello C, Chevernick P, Sotomayor EM, Sokol L, Shah B.

Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S170-4. doi: 10.1016/j.clml.2016.02.024.

PMID:
27521314
16.

Recurrent Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma Presenting as a Breast Implant-Associated Lesion.

Zimmerman A, Locke FL, Emole J, Rosa M, Horna P, Hoover S, Dayicioglu D.

Cancer Control. 2015 Jul;22(3):369-73.

PMID:
26351895
17.

Primary plasmacytoma involving mediastinal lymph nodes: A diagnostic mimicry of primary mediastinal lymphoma.

Salem KZ, Nishihori T, Kharfan-Dabaja MA, Horna P, Alsina M.

Hematol Oncol Stem Cell Ther. 2016 Mar;9(1):26-9. doi: 10.1016/j.hemonc.2015.06.007. Epub 2015 Jul 8.

18.

Flow cytometric identification of immunophenotypically aberrant T-cell clusters on skin shave biopsy specimens from patients with mycosis fungoides.

Horna P, Kurant D, Sokol L, Sotomayor EM, Moscinski L, Glass LF.

Am J Clin Pathol. 2015 Jun;143(6):785-96. doi: 10.1309/AJCPWE2HBFCGDIDS.

PMID:
25972320
19.

A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution.

Peker D, Padron E, Bennett JM, Zhang X, Horna P, Epling-Burnette PK, Lancet JE, Pinilla-Ibarz J, Moscinski L, List AF, Komrokji RS, Zhang L.

Acta Haematol. 2015;133(2):249-56. doi: 10.1159/000365877. Epub 2014 Nov 20.

PMID:
25413011
20.

Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease.

Deaver D, Horna P, Cualing H, Sokol L.

Cancer Control. 2014 Oct;21(4):313-21. Review.

PMID:
25310212
21.

Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.

Riaz W, Zhang L, Horna P, Sokol L.

Cancer Control. 2014 Oct;21(4):279-89. Review.

PMID:
25310209
22.

Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.

Horna P, Zhang L, Sotomayor EM, Lancet JE, Moscinski LC.

Am J Clin Pathol. 2014 Oct;142(4):546-52. doi: 10.1309/AJCPPOKEHBP53ZHV.

23.

Tetraploidy acute promyelocytic leuemia with double t(15;17)/PML-RARA, a case report with review of literature.

Dalia SM, Horna P, Zhang L.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):5363-8. eCollection 2014. Review.

24.

Therapy-related B lymphoblastic leukemia with t(4;11)(q21;q23)/AF4-MLL in a patient with mantle cell lymphoma after recent aggressive chemotherapy: a unique case report.

Holdener SL, Harrington L, Nguyen J, Horna P, Sagatys E, Shah B, Zhang L.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1800-4. eCollection 2014. Review.

25.

Transformation to Hodgkin lymphoma in chronic lymphocytic leukemia coexisting with Epstein-Barr viremia.

Dalia S, Brayer J, Horna P, Zhang H, Pinilla-Ibarz J.

Leuk Lymphoma. 2014 Nov;55(11):2660-2. doi: 10.3109/10428194.2014.894193. Epub 2014 Mar 18. No abstract available.

PMID:
24528217
26.

Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.

Horna P, Deaver DM, Qin D, Moscinski LC, Sotomayor EM, Glass LF, Sokol L.

J Clin Pathol. 2014 May;67(5):431-6. doi: 10.1136/jclinpath-2013-201748. Epub 2013 Dec 6.

PMID:
24319102
27.

Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.

Horna P, Pantazopoulos P, Lancet JE, Moscinski LC, Zhang L.

Leuk Lymphoma. 2014 Aug;55(8):1952-4. doi: 10.3109/10428194.2013.869330. Epub 2014 Feb 6. No abstract available.

PMID:
24304373
28.

Primary cutaneous plasmablastic lymphoma in an immunocompetent patient.

Horna P, Hamill JR Jr, Sokol L, Glass LF.

J Am Acad Dermatol. 2013 Nov;69(5):e274-e276. doi: 10.1016/j.jaad.2013.06.050. No abstract available.

PMID:
24124865
29.

Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

Youn JI, Kumar V, Collazo M, Nefedova Y, Condamine T, Cheng P, Villagra A, Antonia S, McCaffrey JC, Fishman M, Sarnaik A, Horna P, Sotomayor E, Gabrilovich DI.

Nat Immunol. 2013 Mar;14(3):211-20. doi: 10.1038/ni.2526. Epub 2013 Jan 27.

30.

Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.

Cheng F, Wang H, Horna P, Wang Z, Shah B, Sahakian E, Woan KV, Villagra A, Pinilla-Ibarz J, Sebti S, Smith M, Tao J, Sotomayor EM.

Cancer Res. 2012 Sep 1;72(17):4440-8. doi: 10.1158/0008-5472.CAN-11-3619. Epub 2012 Jun 22.

31.

Flow cytometric analysis of surface light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies.

Horna P, Olteanu H, Kroft SH, Harrington AM.

Am J Clin Pathol. 2011 Dec;136(6):954-9. doi: 10.1309/AJCP3C2QZZBPTMLB.

PMID:
22095382
32.

Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3.

Brayer J, Cheng F, Wang H, Horna P, Vicente-Suarez I, Pinilla-Ibarz J, Sotomayor EM.

Immunol Lett. 2010 Jul 8;131(2):126-30. doi: 10.1016/j.imlet.2010.03.004. Epub 2010 Mar 25.

33.

Identification of a novel negative role of flagellin in regulating IL-10 production.

Vicente-Suarez I, Takahashi Y, Cheng F, Horna P, Wang HW, Wang HG, Sotomayor EM.

Eur J Immunol. 2007 Nov;37(11):3164-75.

34.

Cellular and molecular mechanisms of tumor-induced T-cell tolerance.

Horna P, Sotomayor EM.

Curr Cancer Drug Targets. 2007 Feb;7(1):41-53. Review.

PMID:
17305477
35.

In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity.

Horna P, Cuenca A, Cheng F, Brayer J, Wang HW, Borrello I, Levitsky H, Sotomayor EM.

Blood. 2006 Apr 1;107(7):2871-8. Epub 2005 Dec 8.

36.

Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance.

Wang H, Cheng F, Cuenca A, Horna P, Zheng Z, Bhalla K, Sotomayor EM.

Blood. 2005 Feb 1;105(3):1135-43. Epub 2004 Sep 28.

37.

Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens.

Cuenca A, Cheng F, Wang H, Brayer J, Horna P, Gu L, Bien H, Borrello IM, Levitsky HI, Sotomayor EM.

Cancer Res. 2003 Dec 15;63(24):9007-15.

Supplemental Content

Support Center